ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 127 filers reported holding ENDOLOGIX INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $120,000 | +46.3% | 21,139 | +9.5% | 0.00% | 0.0% |
| Q1 2018 | $82,000 | -23.4% | 19,300 | -3.5% | 0.00% | 0.0% |
| Q4 2017 | $107,000 | -35.9% | 20,000 | -46.7% | 0.00% | -50.0% |
| Q3 2017 | $167,000 | -31.3% | 37,500 | -25.0% | 0.01% | -40.0% |
| Q2 2017 | $243,000 | -32.9% | 50,000 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $362,000 | +50.8% | 50,000 | +19.0% | 0.01% | +16.7% |
| Q4 2016 | $240,000 | -89.2% | 42,000 | -67.7% | 0.01% | -87.9% |
| Q1 2015 | $2,219,000 | -3.3% | 130,000 | -13.3% | 0.10% | +25.3% |
| Q4 2014 | $2,294,000 | +44.3% | 150,000 | 0.0% | 0.08% | +102.6% |
| Q3 2014 | $1,590,000 | -30.3% | 150,000 | 0.0% | 0.04% | -22.0% |
| Q2 2014 | $2,282,000 | -15.6% | 150,000 | -28.6% | 0.05% | -7.4% |
| Q1 2014 | $2,703,000 | +4.3% | 210,000 | +41.3% | 0.05% | -3.6% |
| Q4 2013 | $2,592,000 | -55.4% | 148,600 | -58.7% | 0.06% | -11.1% |
| Q3 2013 | $5,810,000 | +143.1% | 360,000 | +100.0% | 0.06% | -10.0% |
| Q2 2013 | $2,390,000 | – | 180,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $5,450,000 | 2.37% |
| Essex Woodlands Management, Inc. | 1,257,468 | $11,699,000 | 2.12% |
| Redmile Group, LLC | 6,368,299 | $30,950,000 | 1.88% |
| Camber Capital Management LP | 7,500,000 | $36,450,000 | 1.78% |
| Sio Capital Management, LLC | 493,060 | $2,396,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 1,575,000 | $7,655,000 | 1.10% |
| PFM Health Sciences, LP | 5,599,466 | $27,213,000 | 0.73% |
| Elk Creek Partners, LLC | 2,087,238 | $10,144,000 | 0.66% |
| Partner Investment Management, L.P. | 99,736 | $485,000 | 0.65% |
| Brown Capital Management | 8,783,162 | $42,686,000 | 0.52% |